Skip to Content
DAEWOONG PHARMACEUTICAL CO.LTD.
About Daewoong
About Daewoong
Global Network
Company Culture
History
Ethics
Contact Us
R&D
R&D Centers
R&D Projects
Achievements
Research Result
Platform Technology
Manufacturing Capabilities
Plants
Smart Factory
FDF CDMO
Product
Biologics
Chemicals
CTD List
Newsroom
Press Release
PR Videos
Investors
Overview
Corporate Governance
Annual Reports
Stock Info
IR
Careers
EN
KR
EN
View all menu
About Daewoong
About Daewoong
Our Purpose
CEO Message
Affiliates
Global Network
Company Culture
History
Ethics
Compliance Program
CEO Message
CP Rating
CP Activities
Contact Us
R&D
R&D Centers
R&D Projects
Achievements
Research Result
Platform Technology
Manufacturing
Capabilities
Plants
Smart Factory
FDF CDMO
Product
Biologics
Chemicals
CTD List
Newsroom
Press Release
PR Videos
Investors
Overview
Corporate Governance
Overview
Board of Directors
Stockholder Info
Stockholder's meeting
Annual Reports
Balance Sheet
Income Statement
Credit Rating
Stock Info
Stock Info
Stock Status
IR
Events & Presentations
Earnings announcement
FAQ
Careers
Daewoong
Global Healthcare Group
The Best Partner for You
Corporate Governance
Governance of Daewoong Pharmaceutical
Overview
Board of Directors
Stockholder Info
Stockholder's meeting
Stockholder's meeting
Major Agendas and Resolutions of the General Meeting of Stockholders
21st Daewoong Pharmaceutical Regular Meeting of Stockholders
view
1. Time
March 29 (Tue), 2023, 09:00
2. Location
Daewoong Pharmaceutical HQ Bear Hall
3. Meeting Objectives
A. Report Items
Audit report and sales report
Report on the 21st financial statement and consolidated financial statement
Report on internal accounting management system operations status
B. Motioned Bills
Agenda 1: Designation of director (one inside director / one outside director)
Agenda 2: Approval of director compensation limit
Agenda 3: Approval of auditor compensation limit
Daewoong Pharmaceutical Regular Meeting of Stockholders
No. of stocks issued
No. of stocks with voting rights
No. of stocks attending
No. of stocks attending(majority shareholder and affiliates)
No. of stocks attending, excluding majority shareholder and affiliates
Voting rights, excluding majority shareholder and affiliates(%)
11,586,575
11,069,208
8,666,832
6,528,338
2,138,494
24.67%
Stockholder's meeting, 21st
General
Stockholder's meeting, 21st
2023.3.29
Stockholder's meeting, 21st
Agenda
Type of Resolution (Ordinary/Special)
Motioned Bills
Remarks
No. of stocks with voting rights(①)
No. of stocks attending(A)
stocks, For(B)
(Ratio, %)
No. of stocks, Against · Abstain(C)
(Ratio, %)
Agenda 1-1
Ordinary
Designation of director (nominee Seongsoo Park)
Approved
11,069,208
8,666,832
8,615,979
(99.41%)
50,853
(0.59%)
Agenda 1-2
Ordinary
Designation of director (nominee Yong-Jin Kim)
Approved
11,069,208
8,666,832
8,631,400
(99.59%)
35,432
(0.41%)
Agenda 2
Ordinary
Approval of director compensation limit (3 Bil. Won)
Approved
11,069,208
8,666,832
8,631,364
(99.59%)
35,468
(0.41%)
Agenda 3
Ordinary
Approval of auditor compensation limit (200 Mil. Won)
Approved
11,069,208
8,666,832
8,631,554
(99.59%)
35,278
(0.41%)
20th Daewoong Pharmaceutical Regular Meeting of Stockholders
view
1. Time
March 29 (Tue), 2022, 09:00
2. Location
Daewoong Pharmaceutical HQ Bear Hall
3. Meeting Objectives
A. Report Items
Audit report and sales report
Report on the 20th financial statement and consolidated financial statement
Report on internal accounting management system operations status
Report on outside auditor designation
B. Motioned Bills
Agenda 1: Change of articles of association
Agenda 2: Designation of director (one outside director)
Agenda 3: Approval of director compensation limit
Agenda 4: Approval of auditor compensation limit
Agenda 5: Approval of granting stock options
Daewoong Pharmaceutical Regular Meeting of Stockholders
No. of stocks issued
No. of stocks with voting rights
No. of stocks attending
No. of stocks attending(majority shareholder and affiliates)
No. of stocks attending, excluding majority shareholder and affiliates
Voting rights, excluding majority shareholder and affiliates(%)
11,586,575
11,069,208
8,274,125
6,658,336
1,615,789
19.53%
Stockholder's meeting, 20th
General
Stockholder's meeting, 20th
2022.3.29
Stockholder's meeting, 20th
Agenda
Type of Resolution (Ordinary/Special)
Motioned Bills
Remarks
No. of stocks with voting rights(①)
No. of stocks attending(A)
stocks, For(B)
(Ratio, %)
No. of stocks, Against · Abstain(C)
(Ratio, %)
Agenda 1
Special
Change of articles of association
Approved
11,069,208
8,274,125
8,091,942
(97.80%)
182,183
(2.20%)
Agenda 2
Ordinary
Designation of director(nominee Dae-duk Kim)
Approved
11,069,208
8,274,125
8,200,622
(99.11%)
73,503
(0.89%)
Agenda 3
Ordinary
Approval of director compensation limit (3 Bil. Won)
Approved
11,069,208
8,274,125
7,341,889
(88.73%)
932,236
(11.27%)
Agenda 4
Ordinary
Approval of auditor compensation limit (200 Mil. Won)
Approved
11,069,208
8,274,125
8,197,876
(99.08%)
76,249
(0.92%)
Agenda 5
Ordinary
Approval of granting stock options
Approved
11,069,208
8,274,125
8,196,118
(99.06%)
78,007
(0.94%)
19th Daewoong Pharmaceutical Regular Meeting of Stockholders
view
1. Time
March 26 (Fri), 2021, 09:00
2. Location
Daewoong Pharmaceutical HQ Bear Hall
3. Meeting Objectives
A. Report Items
Audit report and sales report
Report on the 19th financial statement and consolidated financial statement
Report on internal accounting management system operations status
Report on outside auditor designation
B. Motioned Bills
Agenda 1: Change of articles of association
Agenda 2: Designation of directors (three executive directors, two outside directors)
Agenda 3: Designation of auditor (one fulltime auditor)
Agenda 4: Approval of director compensation limit
Agenda 5: Approval of auditor compensation limit
Agenda 6: Approval of granting stock options
18th Daewoong Pharmaceutical Regular Meeting of Stockholders
view
1. Time
March 30 (Fri), 2020, 09:00
2. Location
Daewoong Pharmaceutical HQ Bear Hall
3. Meeting Objectives
A. Report Items
Audit report and sales report
Report on the 18th financial statement and consolidated financial statement
Report on internal accounting management system operations status
B. Motioned Bills
Agenda 2: Change of articles of association
Agenda 3: Case of appointing auditors
Agenda 4: Approval of director compensation limit
Agenda 5: Approval of auditor compensation limit
17th Daewoong Pharmaceutical Regular Meeting of Stockholders
view
1. Time
March 22 (Fri), 2019, 09:00
2. Location
Daewoong Pharmaceutical HQ Bear Hall
3. Meeting Objectives
A. Report Items
Audit report and sales report
Report on the 17th financial statement and consolidated financial statement
Report on internal accounting management system operations status
B. Motioned Bills
Agenda 1: Change of articles of association
Agenda 2: Approval of director compensation limit
Agenda 3: Approval of auditor compensation limit
Agenda 4: Approval of granting stock options
16th Daewoong Pharmaceutical Regular Meeting of Stockholders
view
1. Time
March 23 (Fri), 2018, 09:00
2. Location
Daewoong Pharmaceutical HQ Bear Hall
3. Meeting Objectives
A. Report Items
Audit report and sales report
Report on the 16th financial statement and consolidated financial statement
B. Motioned Bills
Agenda 1: Case of appointing directors (2 in-company directors, 1 outside director)
Agenda 2: Approval of director compensation limit
Agenda 3: Approval of auditor compensation limit
Agenda 4: Change of articles of association